Enzo Biochem (ENZ) reported Q4 EPS of (17c)
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q4 EPS of ($0.17). Revenue for the quarter came in at $20.28 million.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Jefferies Starts Frencken Group Ltd. (FRKN:SP) at Buy
- Progress Software completes $400M acquisition of Domo's data platform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
